TransMedics Group, Inc. (TMDX) Shares Outstanding: 0.03
Is TransMedics Group, Inc.’s shares outstanding high or low?
TransMedics Group, Inc.'s shares outstanding of 0.03 is 12% above its 5-year average of 0.03, near the high end of its 5-year range (0.02–0.03).
1.14% above its 12-month average of 0.03.
TMDX Shares Outstanding Chart
TMDX Average Shares Outstanding Chart
TMDX Current vs Average Shares Outstanding Chart
TMDX Shares Outstanding Metrics
SHARES OUTSTANDING
0.03
SHARES OUTSTANDING AVG TTM
0.03
SHARES OUTSTANDING AVG 3Y
0.03
SHARES OUTSTANDING AVG 5Y
0.03
SHARES OUTSTANDING AVG 10Y
N/A
SHARES OUTSTANDING AVG 15Y
N/A
SHARES OUTSTANDING AVG 20Y
N/A
CURRENT VS TTM AVG
+1.14%
CURRENT VS 3Y AVG
+5.16%
CURRENT VS 5Y AVG
+12.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Share Structure
Shares Outstanding
33.99M
Float Shares
N/A
Stock Price
$78.79
Market Cap
$2.7B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 33.99M | +2.30% |
| 2024 | 33.23M | +2.19% |
| 2023 | 32.52M | +10.02% |
| 2022 | 29.56M | +7.02% |
| 2021 | 27.62M | +11.80% |
| 2020 | 24.70M | +73.90% |
| 2019 | 14.20M | -26.19% |
| 2018 | 19.25M | +32.93% |
| 2017 | 14.48M | +0.00% |
| 2016 | 14.48M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
TransMedics Group, Inc. Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
TransMedics Group, Inc. Shares Outstanding FAQ
- What is the shares outstanding for TransMedics Group, Inc. (TMDX)?
- The shares outstanding for TMDX stock is 0.03.
- Is TransMedics Group, Inc.'s shares outstanding high or low?
- TransMedics Group, Inc.'s shares outstanding of 0.03 is 12% above its 5-year average of 0.03, near the high end of its 5-year range (0.02–0.03).
- What is the TTM average shares outstanding for TransMedics Group, Inc. (TMDX)?
- The TTM average shares outstanding for TMDX stock is 0.03.
- What is the 3Y average shares outstanding for TransMedics Group, Inc. (TMDX)?
- The 3Y average shares outstanding for TMDX stock is 0.03.
- What is the 5Y average shares outstanding for TransMedics Group, Inc. (TMDX)?
- The 5Y average shares outstanding for TMDX stock is 0.03.
TransMedics Group, Inc. Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-31 | 0.03 |
| 2024-12-31 | 0.03 |
| 2023-12-31 | 0.03 |
| 2022-12-31 | 0.03 |
| 2021-12-31 | 0.03 |
| 2020-12-31 | 0.02 |
| 2019-12-31 | 0.01 |
| 2018-12-31 | 0.02 |
| 2017-12-31 | 0.01 |
| 2016-12-31 | 0.01 |
Related Metrics
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein